Nevirapine use at birth linked to greater odds of drug resistance

01/1/2013 | Healio

Administration of extended nevirapine prophylaxis among babies infected with HIV by 6 weeks of age was associated with a higher risk of resistance to the drug later, compared with babies who didn't have HIV at 6 weeks but did by 6 months of age, a study showed. The findings were reported in the Pediatric Infectious Disease Journal.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN